Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1955 1
1956 1
1958 3
1959 1
1964 1
1966 1
1967 1
1973 1
1975 1
1976 1
1978 1
1979 1
1982 1
1985 1
1990 1
1991 1
1993 1
1996 1
1998 1
1999 1
2000 1
2001 4
2002 3
2003 5
2004 3
2005 2
2006 2
2007 10
2008 4
2009 12
2010 8
2011 8
2012 5
2013 3
2014 4
2015 1
2016 5
2017 4
2018 1
2019 5
2020 6
2021 1
2022 3
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial.
Ray-Coquard I, Leary A, Pignata S, Cropet C, González-Martín A, Marth C, Nagao S, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alia EM, Bogner G, Yoshida H, Lefeuvre-Plesse C, Buderath P, Mosconi AM, Lortholary A, Burges A, Medioni J, El-Balat A, Rodrigues M, Park-Simon TW, Dubot C, Denschlag D, You B, Pujade-Lauraine E, Harter P; PAOLA-1/ENGOT-ov25 investigators. Ray-Coquard I, et al. Among authors: medioni j. Ann Oncol. 2023 Aug;34(8):681-692. doi: 10.1016/j.annonc.2023.05.005. Epub 2023 May 19. Ann Oncol. 2023. PMID: 37211045 Free article. Clinical Trial.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
Wirth LJ, Sherman E, Robinson B, Solomon B, Kang H, Lorch J, Worden F, Brose M, Patel J, Leboulleux S, Godbert Y, Barlesi F, Morris JC, Owonikoko TK, Tan DSW, Gautschi O, Weiss J, de la Fouchardière C, Burkard ME, Laskin J, Taylor MH, Kroiss M, Medioni J, Goldman JW, Bauer TM, Levy B, Zhu VW, Lakhani N, Moreno V, Ebata K, Nguyen M, Heirich D, Zhu EY, Huang X, Yang L, Kherani J, Rothenberg SM, Drilon A, Subbiah V, Shah MH, Cabanillas ME. Wirth LJ, et al. Among authors: medioni j. N Engl J Med. 2020 Aug 27;383(9):825-835. doi: 10.1056/NEJMoa2005651. N Engl J Med. 2020. PMID: 32846061 Free PMC article. Clinical Trial.
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs).
Daban A, Gonnin C, Phan L, Saldmann A, Granier C, Lillo-Lelouet A, Le Beller C, Pouchot J, Weiss L, Tartour E, Fabre E, Medioni J, Oudard S, Vano YA, Dragon-Durey MA, Simonaggio A. Daban A, et al. Among authors: medioni j. Oncoimmunology. 2023 May 11;12(1):2204754. doi: 10.1080/2162402X.2023.2204754. eCollection 2023. Oncoimmunology. 2023. PMID: 37187974 Free PMC article.
[Prostate cancer: update].
Oudard S, Medioni J, Scotté F, Banu E. Oudard S, et al. Among authors: medioni j. Bull Cancer. 2005 Oct;92(10):865-73. Bull Cancer. 2005. PMID: 16266870 Free article. Review. French.
[Hereditary breast and ovarian cancer syndrome: Diagnosis and therapeutic implications].
Koual M, Perkins G, Delanoy N, Crespel C, Medioni J, Nguyen-Xuan HT, Douay-Hauser N, Blons H, Le Frère-Belda MA, Molière D, Achen G, Nos C, Balaya V, Montero R, Laurent-Puig P, Bats AS. Koual M, et al. Among authors: medioni j. Ann Pathol. 2020 Apr;40(2):70-77. doi: 10.1016/j.annpat.2020.01.004. Epub 2020 Feb 8. Ann Pathol. 2020. PMID: 32046878 Review. French.
[Targeting the RAS signalling pathway in cancer].
Mansi L, Viel E, Curtit E, Medioni J, Le Tourneau C. Mansi L, et al. Among authors: medioni j. Bull Cancer. 2011 Oct;98(9):1019-28. doi: 10.1684/bdc.2011.1380. Bull Cancer. 2011. PMID: 21715253 Free article. Review. French.
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Blanchet B, Xu-Vuilard A, Jouinot A, Puisset F, Combarel D, Huillard O, Le Louedec F, Thomas F, Teixeira M, Flippot R, Mourey L, Albiges L, Pudlarz T, Joly C, Tournigand C, Chauvin J, Puszkiel A, Chatelut E, Decleves X, Vidal M, Goldwasser F, Oudard S, Medioni J, Vano YA. Blanchet B, et al. Among authors: medioni j. Br J Cancer. 2024 Apr;130(6):961-969. doi: 10.1038/s41416-024-02585-y. Epub 2024 Jan 25. Br J Cancer. 2024. PMID: 38272963
[Nausea and vomiting in cancer patients].
Lévy E, Scotté F, Médioni J, Oudard S. Lévy E, et al. Among authors: medioni j. Rev Prat. 2006 Nov 30;56(18):2015-9. Rev Prat. 2006. PMID: 17274504 Review. French.
Management of neuropathic pain induced by surgery: Review of the literature by a group of experts specialized in pain management, anesthesia and surgery.
Prudhomme M, Legras A, Delorme C, Lansaman T, Lanteri-Minet M, Medioni J, Navez M, Perrot S, Pickering G, Serrie A, Viel E. Prudhomme M, et al. Among authors: medioni j. J Visc Surg. 2020 Feb;157(1):43-52. doi: 10.1016/j.jviscsurg.2019.09.004. Epub 2019 Oct 24. J Visc Surg. 2020. PMID: 31668838 Free article. Review.
119 results